Body mass index influences the response to infliximab in ankylosing spondylitis

INTRODUCTION: The excess of adipose tissue in obese individuals may have immunomodulating properties and pharmacokinetic consequences. The aim of this study was to determine whether body mass index (BMI) affects response to infliximab (IFX) in ankylosing spondylitis (AS) patients. METHODS: In 155 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottaviani, Sébastien, Allanore, Yannick, Tubach, Florence, Forien, Marine, Gardette, Anaïs, Pasquet, Blandine, Palazzo, Elisabeth, Meunier, Marine, Hayem, Gilles, Job-Deslandre, Chantal, Kahan, André, Meyer, Olivier, Dieudé, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446492/
https://www.ncbi.nlm.nih.gov/pubmed/22584116
http://dx.doi.org/10.1186/ar3841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446492/
https://www.ncbi.nlm.nih.gov/pubmed/22584116
http://dx.doi.org/10.1186/ar3841

Ejemplares similares